TNFSF10 and HIV infectious disease: To assess this possibility, cells were stained on day 0 (immediately following HIV infection) with CFSE and proliferation assessed by comparing CFSE dilution between HIV-infected but untreated, and HIV-infected but TRAIL-treated cells (Fig. 2B).